The upregulation of CRP and pro-inflammatory cytokines in these well-controlled T1DM patients further validates the inflammatory state and its potential sequential contribution to the development of CVD, as a model of subclinical CVD. This evidence concerns the gene CRP and type 1 diabetes mellitus.